When Surgical Delay Is Not Negotiable If the B12 deficiency is severe (particularly if below 100 pmol/L or with neurological symptoms), I do not proceed, regardless of the patients preferences regarding timing
Demographics: Baseline characteristics reflected a real-world population (median age 64), with 35% of patients presenting with high-risk cytogenetics and 40% with soft-tissue plasmacytomas
59,72,73 One study in pain-sensitized mice found neutrophils invaded peripheral sensory nerves and increased their pain signaling, whereas neutrophil depletion prevented the mice from developing chronic widespread pain
This regulatory status has important implications: Quality and Sourcing: Product quality varies significantly between suppliers No standardized manufacturing requirements Purity and concentration may be inconsistent Third-party testing essential for quality verification Legal Considerations: Not approved for human consumption by FDA Sold for research purposes only Individual use decisions carry personal responsibility Medical supervision strongly recommended Athletic Considerations: Banned by World Anti-Doping Agency (WADA) Classified as S0 Non-Approved Substance Prohibited for competitive athletes May result in positive drug tests and sanctions 5-AMINO-1MQ RESULTS: WHAT TO EXPECT Timeline for Visible Results Understanding the timeline for 5 amino 1mq results helps set realistic expectations and maintain motivation throughout treatment
We might suggest starting with 2,000-5,000 mcg injections to help with severe symptoms
